ChemicalBook > CAS DataBase List > Mutated EGFR-IN-1

Mutated EGFR-IN-1

Product Name
Mutated EGFR-IN-1
CAS No.
1421372-66-8
Chemical Name
Mutated EGFR-IN-1
Synonyms
AZD9291 intermediate;OMT-3;CS-1173;HY-78869;AZD9291 3;AZD9291DA;AZD9291 N-2;AZD9291 int-5;Osimertinib N-2;AZD9291 INT1 N-2
CBNumber
CB22715656
Molecular Formula
C25H31N7O
Formula Weight
445.56
MOL File
1421372-66-8.mol
More
Less

Mutated EGFR-IN-1 Property

Boiling point:
676.5±65.0 °C(Predicted)
Density 
1.21±0.1 g/cm3(Predicted)
storage temp. 
Store at -20°C
solubility 
DMSO: ≥ 75 mg/mL (168.33 mM)
pka
9.07±0.28(Predicted)
form 
Powder
Appearance
Off-white to gray Solid
InChIKey
HTNTZPBKKCORTP-UHFFFAOYSA-N
SMILES
C1(N(CCN(C)C)C)=CC(OC)=C(NC2=NC=CC(C3C4=C(N(C)C=3)C=CC=C4)=N2)C=C1N
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Warning
Hazard statements

H302Harmful if swallowed

H315Causes skin irritation

H319Causes serious eye irritation

H335May cause respiratory irritation

Precautionary statements

P261Avoid breathing dust/fume/gas/mist/vapours/spray.

P301+P312IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.

P302+P352IF ON SKIN: wash with plenty of soap and water.

P304+P340IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.

P305+P351+P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.

More
Less

N-Bromosuccinimide Price

TRC
Product number
D470923
Product name
N1-​[2-​(Dimethylamino)​ethyl]​-​5-​methoxy-​N1-​methyl-​N4-​[4-​(1-​methyl-​1H-​indol-​3-​yl)​-​2-​pyrimidinyl]​-​1,​2,​4-​benzenetriamine
Packaging
10mg
Price
$205
Updated
2021/12/16
ChemScene
Product number
CS-3259
Product name
MutatedEGFR-IN-1
Purity
99.36%
Packaging
5g
Price
$400
Updated
2021/12/16
Biorbyt Ltd
Product number
orb611848
Product name
Mutated EGFR-IN-1
Packaging
10mg
Price
$414.8
Updated
2021/12/16
AK Scientific
Product number
0008AP
Product name
N1-[2-(Dimethylamino)ethyl]-5-methoxy-N1-methyl-N4-[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]-1,2,4-benzenetriamine
Packaging
1mg
Price
$145
Updated
2021/12/16
Biorbyt Ltd
Product number
orb611848
Product name
Mutated EGFR-IN-1
Packaging
50mg
Price
$674.9
Updated
2021/12/16
More
Less

Mutated EGFR-IN-1 Chemical Properties,Usage,Production

Uses

N1-?[2-?(Dimethylamino)?ethyl]?-?5-?methoxy-?N1-?methyl-?N4-?[4-?(1-?methyl-?1H-?indol-?3-?yl)?-?2-?pyrimidinyl]?-?1,?2,?4-?benzenetriamine can be involved as reactant/reagent in "Schizophrenic" self-assembly of dual thermoresponsive block copolymers bearing a zwitterionic and a non-ionic hydrophilic block.

Synthesis

1421372-67-9

1421372-66-8

Under nitrogen protection, 28.5 g (0.060 mol) of N1-(2-(dimethylamino)ethyl)-5-methoxy-N1-methyl-N4-(4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)-2-nitrobenzene-1,4-diamine was added to 500 mL of methanol with 2.5 g of palladium carbon catalyst. The reaction was stirred at 25 °C for 4 hours in a hydrogen atmosphere. Upon completion of the reaction, the catalyst was removed by filtration and the filtrate was concentrated to dryness under reduced pressure to afford 26 g of the brown solid product N1-[2-(dimethylamino)ethyl]-5-methoxy-N1-methyl-N4-[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]-1,2,4-benzenetriamine in 97.3% yield.

IC 50

EGFRL858R; EGFRExon 19 deletion/T790M; EGFRT790M

References

[1] Patent: CN107216313, 2017, A. Location in patent: Paragraph 0058; 0059; 0071; 0072
[2] Patent: CN108129342, 2018, A. Location in patent: Paragraph 0054; 0055; 0056
[3] Patent: CN107188888, 2017, A. Location in patent: Paragraph 0067-0069; 0070-0072
[4] Journal of Heterocyclic Chemistry, 2017, vol. 54, # 5, p. 2898 - 2901
[5] Patent: CN107793413, 2018, A. Location in patent: Paragraph 0180; 0181; 0184; 0185

Mutated EGFR-IN-1 Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Mutated EGFR-IN-1 Suppliers

China 215 India 6 United States 12 Global 233
Musechem
Tel
+1-800-259-7612
Fax
+1-800-259-7612
Email
info@musechem.com
Country
United States
ProdList
4660
Advantage
60
TargetMol Chemicals Inc.
Tel
+1-781-999-5354; +17819995354
Email
marketing@targetmol.com
Country
United States
ProdList
32435
Advantage
58
InvivoChem
Tel
+1-708-310-1919 +1-13798911105
Fax
708-557-7486
Email
sales@invivochem.cn
Country
United States
ProdList
6391
Advantage
58
Cckinase, Inc.
Tel
+1 (732)236-3202
Email
sales@cckinase.com
Country
United States
ProdList
2738
Advantage
58
Standardpharm Co. Ltd.
Tel
86-714-3992388
Email
overseasales1@yongstandards.com
Country
United States
ProdList
14332
Advantage
58
BOC Sciences
Tel
+1-631-485-4226
Fax
1-631-614-7828
Email
inquiry@bocsci.com
Country
United States
ProdList
19552
Advantage
58
Alchem Pharmtech,Inc.
Tel
8485655694
Email
sales@alchempharmtech.com
Country
United States
ProdList
63687
Advantage
58
Aladdin Scientific
Tel
Email
tp@aladdinsci.com
Country
United States
ProdList
52923
Advantage
58
United States Biological
Tel
--
Fax
--
Email
chemicals@usbio.net
Country
United States
ProdList
6214
Advantage
80
MedChemExpress
Tel
--
Fax
--
Email
sales@medchemexpress.com
Country
United States
ProdList
6398
Advantage
58
Combi-Blocks Inc.
Tel
--
Fax
--
Email
sales@combi-blocks.com
Country
United States
ProdList
6618
Advantage
69
Matrix Scientific
Tel
--
Fax
--
Email
sales@matrixscientific.com
Country
United States
ProdList
6632
Advantage
80
More
Less

View Lastest Price from Mutated EGFR-IN-1 manufacturers

Henan Aochuang Chemical Co.,Ltd.
Product
Mutated EGFR-IN-1 1421372-66-8
Price
US $0.00-0.00/kg
Min. Order
1kg
Purity
98%
Supply Ability
1Ton
Release date
2022-09-30
Henan Fengda Chemical Co., Ltd
Product
Mutated EGFR-IN-1 1421372-66-8
Price
US $5.00-0.10/KG
Min. Order
1KG
Purity
98%
Supply Ability
g-kg-tons, free sample is available
Release date
2024-04-09
Zhuozhou Wenxi import and Export Co., Ltd
Product
AZD9291 intermediate 1421372-66-8
Price
US $15.00-10.00/KG
Min. Order
1KG
Purity
99%+ HPLC
Supply Ability
Monthly supply of 1 ton
Release date
2021-07-10

1421372-66-8, Mutated EGFR-IN-1Related Search:

Osimertinib mesylate AZD-9291 N-(4-fluoro-2-Methoxy-5-nitrophenyl)-4-(1-Methylindol-3-yl)pyriMidin-2-aMine 1,4-BenzenediaMine, N1-[2-(diMethylaMino)ethyl]-5-Methoxy-N1-Methyl-N4-[4-(1-Methyl-1H-indol-3-yl)-2-pyriMidinyl]-2-nitro-

  • Mutated EGFR-IN-1
  • HY-78869
  • AZD9291DA HCl salt
  • N1-[2-(diMethylaMino)ethyl]-5-Methoxy-N1-Methyl-N4-[4-(1-Methyl-1H-indol-3-yl)-2-pyriMidinyl]benzene-1,2,4-triamine
  • AZD9291 int-5
  • N1-[2-(Dimethylamino)ethyl]-5-methoxy-N1-methyl-N4-[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]-1,2,4-benzenetriamine
  • 1,2,4-Benzenetriamine, N1-[2-(dimethylamino)ethyl]-5-methoxy-N1-methyl-N4-[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]-
  • AZD9291 3
  • N1-(2-(dimethylamino)ethyl)-5-methoxy-N1-methyl-N4-(4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)benzene-1,2,4-triamine
  • AZD9291 intermediate 4
  • AZD9291 INT1 N-2
  • Osimertinib Impurity 5
  • CS-1173
  • AZD91 intermediate
  • AZD9291 N-2
  • Mutated EGFR-IN-1 (Osimertinib analog)
  • N1-[2-(Dimethylamino)ethyl]-5-methoxy-N1-methyl-N4-[4-(1-m-ethyl-1H-indol-3-yl)-2-pyrimidi-nyl]-1,2,
  • N1-(2-dimethylaminoethyl)-5-methoxy-N1-methyl-N4-[4-(1-methylindol-3-yl)pyrimidin-2-yl]benzene-1,2,4-triamine
  • N-(2-dimethylamino-ethyl)-2-methoxy-n-methyl-n-[4-(1-methyl-1h-indol-3-yl)-pyrimidin-2-yl]-5-Amino-benzene-1,4-diamine
  • AZD9291 Intermediate1
  • Mereletinib Intermediates
  • OMT-3
  • N1-(2-(Dimethylamino)ethyl)-5-methoxy-N1-methyl-N4-(4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)b
  • Osimertinib Intermediate 3
  • AZD9291 intermediates 3
  • Mutated EGFR inhibitor 1
  • Osimertinib analog
  • Osimertinib intermediate
  • AZD9291 intermediate
  • N1-(2-(dimethylamino)ethyl)-5-methoxy-N1-methyl-N4-(4-(1-methyl-1H-indol-3- yl)pyrimidin-2-yl)benzene-1,2-triamine
  • AZD9291DA
  • N1-(2-(Dimethylamino)ethyl)-5-methoxy-N1-methyl-N4-(4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)benzene
  • 1-N-[2-(dimethylamino)ethyl]-5-methoxy-1-N-methyl-4-N-[4-(1-methylindol-3-yl)pyrimidin-2-yl]benzene-1,2,4-triamine
  • N1- [2- (dimethylamino) ethyl] -5-methoxy-N1- methyl-N4- [4- (1-methyl-1H-indole-3-yl) -2-pyrimidinyl] -1,2,4-phenyltriamine
  • Osimertinib N-2
  • N1-[2-(Dimethylamino)ethyl]-5-methoxy-N1-methyl-N4-[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]-1,2,4-
  • Mutated EGFR-IN-1, 10 mM in DMSO
  • N1-[2-(Dimethylamino)ethyl]-5-methoxy-N1-methyl-N4-[4-(1-methyl-3-indolyl)-2-pyrimidinyl]-1,2,4-benzenetriamine
  • Mutated EGFR-IN-1 ，E2251
  • N1-[2-(dimethylamino)ethyl]-5-methoxy-N1-methyl-N4- [4- (1-methyl-1H-indol-3-yl) -2-pyrimidinyl] -1,2,4-phenyltriamine
  • 1421372-66-8
  • AZD9291
  • Pharmaceutical intermediate
  • API